IP Library Granted Patent US 11,008,413
Granted Patent B1
US 11,008,413 · App. 15/923,055 · Granted May 18, 2021

Biocompatible materials for underlid device fabrication

Inventors: Jeffrey George Linhardt (Mountain View, CA); Daniel Barrows (Mountain View, CA); Hojr Pisheh (Mountain View, CA)
Assignee: Verily Life Sciences LLC
C08F230/08G02B1/043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,008,413
App. No.
15/923,055
Granted
May 18, 2021
Kind
B1
Abstract

An eye-mountable composition, an eye-mountable device and a method for making the eye-mountable device are disclosed. In one aspect, an eye-mountable composition is disclosed, which may include a silicone hydrogel having silicon-containing monomer-derived units and hydrophilic monomer-derived units, a non-silicone hydrogel having non-silicon-containing hydrophobic monomer-derived units and hydrophilic monomer-derived units, or an elastomer. The composition is biocompatible, does not adhere to ocular tissue, and has a modulus of elasticity of 0.2 MPa to 10 MPa. Also provided is an eye mountable device including an electronics platform embedded in an eye-mountable composition, and a method for fabricating the eye-mountable device.

Claims (24)

1. An eye-mountable composition, comprising a non-silicon-containing hydrogel comprising:

non-silicon-containing hydrophobic monomer-derived units, wherein the non-silicon-containing hydrophobic monomer-derived units comprise (i) an alkylene oxide (meth)acrylate-derived monomeric unit and (ii) a fluorinated methacrylate-derived monomeric unit; and

hydrophilic monomer-derived units,

wherein the non-silicon-containing hydrogel includes 15-30 wt. % of one or more di(meth)acrylate-derived monomeric units, and 60-85 wt. % of one or more (meth)acrylate-derived monomeric units; and

wherein the non-silicon-containing hydrogel has a water content of 5 weight percent to 90 weight percent and a modulus of elasticity of 0.2 MPa to 10 MPa.

2. The eye-mountable composition of claim 1 , wherein the hydrogel has a water content of 75 weight percent to 90 weight percent.

3. The eye-mountable composition of claim 1 , wherein the composition has a modulus of elasticity of 0.2 MPa to 5 MPa.

4. The eye-mountable composition of claim 1 , wherein the composition has a modulus of elasticity of 0.2 MPa to 1 MPa.

5. The eye-mountable composition of claim 1 , wherein the non-silicon-containing hydrophobic monomer-derived units of the hydrogel further comprise alkyl-containing (meth)acrylate-derived monomeric units with alkyl groups having 1 to 4 carbon atoms per group.

6. An eye-mountable device, comprising an electronics platform embedded in the eye-mountable composition of claim 1 .

7. An eye-mountable composition, comprising:

an elastomer, wherein the elastomer comprises a silicone elastomer, wherein the silicone elastomer includes polyurethane-polysiloxane macromonomers and styrene-isoprene-butadiene-styrene,

wherein the composition has a modulus of elasticity of 0.2 MPa to 10 MPa.

8. The eye-mountable composition of claim 7 , wherein the elastomer further comprises a hydrophobic acrylic, wherein the hydrophobic acrylic has a (meth)acrylate-derived unit having a hydrophobic side chain.

9. The eye-mountable composition of claim 8 , wherein the hydrophobic side chain is linear or branched C 12 alkyl.

10. An eye-mountable device, comprising an electronics platform embedded in the eye-mountable composition of claim 7 .

11. A method for fabricating the eye-mountable device of claim 6 , method comprising:

forming a monomer mixture comprising a non-silicon-containing hydrophobic monomer and a hydrophilic monomer;

depositing the monomer mixture on an electronics platform; and

curing the monomer mixture to provide the eye-mountable device.

12. A method for fabricating the eye-mountable device of claim 10 , the method comprising:

forming a monomer mixture comprising an elastomer precursor;

depositing the monomer mixture on an electronics platform; and

curing the monomer mixture to provide the eye-mountable device.

Assignments (4)
CHANGE OF NAME Recorded Apr 1, 2026
From: VERILY LIFE SCIENCES LLC
To: VERILY HEALTH INC.
Reel/Frame 075367/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2024
From: TWENTY TWENTY THERAPEUTICS LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 068846/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2023
From: VERILY LIFE SCIENCES LLC
To: TWENTY TWENTY THERAPEUTICS LLC
Reel/Frame 064163/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2018
From: LINHARDT, JEFFREY GEORGE; BARROWS, DANIEL; PISHEH, HOJR
To: VERILY LIFE SCIENCES LLC
Reel/Frame 045344/0195 →
Continuity (1)
Provisional Application 62473360 · Mar 18, 2017